Europe and Asia Continuing Medical Education Events Have Been Announced for 2012

Share Article

Imedex® is an industry leader in providing accredited, independent continuing medical education to health care professionals. Imedex® develops high quality, scientific programming that translates the latest research into clinically relevant information. The live continuing medical education activities have exceptional organization and outstanding educational value, with a proven sustained impact on disease management.

Past News Releases

RSS

Imedex® is an industry leader in providing accredited, independent continuing medical education to health care professionals. Imedex® develops high quality, scientific programming that translates the latest research into clinically relevant information. The live continuing medical education activities have exceptional organization and outstanding educational value, with a proven sustained impact on disease management. The continuing medical education programs focus on improving patient care around the world. With over 50,000 e-learning experiences annually and more than 97,000 live meeting attendees since 2001, Imedex® truly educates the global healthcare community. At Imedex®, we believe that “education is the best medicine. ®”

The list of the 2012 Imedex, LLC Europe and Asia events are as follows:

Event: 8th European Congress On Hematologic Malignancies: From Clinical Science To Clinical Practice
When/Where: February 24-26, 2012 in Amsterdam: The Netherlands
Oncology CME Event Summary: In its eight year, the 2012 Congress encompasses hematologic malignancies, including myeloma, lymphoma, and leukemia, as well as discussions on screening, diagnosis and the latest management options. The focus of the 2012 Congress is to provide a forum to review state-of-the-art and present new data, as well as give attendees the opportunity to exchange ideas with world-renowned opinion leaders in the field.
Oncology CME Faculty: Elias Campo, MD, PhD (University of Barcelona), Bertrand Coiffier, MD (Hospices Civils de Lyon), Claire Dearden, MD (The Royal Marsden Hospital), Meletios A. Dimopoulos, MD (University of Athens School of Medicine), Martin Dreyling, MD (University Hospital Munich), Michael Hallek, MD (University of Cologne), Olivier Hermine, MD, PhD (Hópital Necker), Peter Johnson, MD (Cancer Research UK Centre University of Southampton), Eva Kimby, MD, PhD (Karolinska Institute, Karolinska University Hospital), Hanneke Kluin-Nelemans, MD, Maria-Victoria Mateos, MD, PhD (University Hospital of Salamanca), Philippe Moreau, MD (University Hospital Nantes), Antonio Palumbo, MD (University of Torino), Gilles Salles, MD , PhD (Hospices Civils de Lyon), Marinus H.J. van Oers, MD, PhD (Academic Medical Center), Pier Luigi Zinzani, MD (University of Bologna)
Target Audience: Hematologists, oncologists, and other healthcare professionals (physicians, physicians-in-training, oncology nurses, pharmacists, physicians' assistants, etc.) involved and/or interested in the therapeutic management of patients with hematologic malignancies, including multiple myeloma, chronic lymphocytic leukemia, and Hodgkin's and non-Hodgkin lymphomas.

Click Here to Register for the Oncology CME

Event: 13th European Congress: Perspectives in Lung Cancer
When/Where: March 9-10, 2012 in Amsterdam: The Netherlands
Oncology CME Event Summary: Guided by an interactive format, Perspectives in Lung Cancer will not only provide a comprehensive overview of the most significant advances in lung cancer treatment, but will also leave attendees with valuable take-home information. Lectures, meet-the-expert sessions, and panel discussions, will aid attendees in confirming their current practices, increase their knowledge of lung cancer and optimize their patient care.
Target Audience: Medical oncologists, radiation oncologists, thoracic surgeons, pulmonologists, and other physicians, clinicians, physicians-in-training, and healthcare professionals (nurses, pharmacists, physician assistants, etc.) involved and/or interested in the therapeutic management of patients with lung cancer.

Click Here to Register for the Oncology CME

Event: 2012 European Focus On Myeloproliferative Neoplasms And Myelodysplastic Syndromes
When/Where: May 4-5, 2012 in Lisbon, Portugal
Oncology CME Event Summary: The 2012 European Focus on Myeloproliferative Neoplasms and Myelodysplastic Syndromes Oncology CME event will be the first comprehensive Congress of its kind in Europe. This meeting promises to be a first-class educational event that focuses on the latest advances in MPD, MDS and MPN. At this Congress, attendees will network with nationally-recognized leaders in the fields of molecular biology, pathology, immunology, and translational and clinical research, as this Congress promises to be a stimulating, interactive educational opportunity for attendees.
Oncology CME Faculty: Tiziano Barbui, MD (Ospedali Riuniti di Bergamo), Giovani Barosi, MD (IRCCS Policlinico San Matteo), Mario Cazzola. MD (University of Pavia Medical School), Francisco Cervantes, MD, PhD (Hospital Clinic Barcelona), Stefan Constantinescu, MD, PhD (Ludwig Institute for Cancer Research), Theo De Witte, MD, PhD (University Medical Center Nijmegen St. Radboud), Francois Delhommeau, MD, PhD (AP-HP Hopital Saint Antoine), Pierre Fenaux, MD (Hôpital Avicenne, University Paris 13), Heinz Gisslinger, MD (Medical University of Vienna), Anthony R. Green, PhD, FRCP, FRCPath (Cambridge Institute for Medical Research), Claire Harrison, MD (Guy's and St. Thomas Hospital), Laurent Knoops, MD, PhD (Université catholique de Louvain), Robert Kralovics, PhD (Center for Molecular Medicine), Nicolaus Kröger, MD (University Medical Center Hamburg), Richard T. Silver, MD, FACP (Weill Cornell Medical College), Evangelos Terpos, MD (University of Athens School of Medicine), Felicitas Thol, MD (Hannover Medical School), Alessandro M. Vannucchi, MD (University of Florence) and Srdan Verstovsek, MD, PhD (The University of Texas M. D. Anderson Cancer Center)
Target Audience: Hematologists, oncologists, and other health-care professionals (physicians, physicians-in-training, oncology nurses, pharmacists, physicians' assistants, etc.) involved and/or interested in the therapeutic management of patients with myelodysplastic syndromes and myeloproliferative diseases.

Click Here to Register for the Oncology CME

Event: ESMO 14th World Congress on Gastrointestinal Cancer
When/Where: June 27-30, 2012 in Barcelona, Spain
Gastrointestinal/Oncology CME Event Summary: The ESMO 14th World Congress on Gastrointestinal Cancer is the premier global event in the field, encompassing malignancies affecting every component of the gastrointestinal tract and aspects related to the care of patients with gastrointestinal cancer, including screening, diagnosis and the latest management options for common and uncommon tumors. It has been endorsed by leading professional societies and organizations.
Gastroenterology/Oncology CME Faculty: Nadir Arber, MD, MSc, MHA (Tel Aviv Medical Center), Andrés Cervantes, MD, PhD (Hospital Clinico de Valencia), Fortunato Ciardiello, MD, PhD (Second University of Naples), Mario Dicato, MD (Luxembourg Medical Center), Bengt Glimelius, MD, PhD (University of Uppsala), Richard M. Goldberg, MD (University of North Carolina), Axel Grothey, MD (Mayo Clinic), Karin Haustermans, MD, PhD (University Hospital Gasthuisberg), Yoon-Koo Kang, MD, PhD (University of Ulsan College of Medicine), David J. Kerr, MD, FRCP (University of Oxford), Roberto Labianca, MD (Riuniti Hospital), John L. Marshall, MD (Georgetown University), Bernard Nordlinger, MD (Ambroise Paré Hospital), Arnaud D. Roth, MD (Geneva University Hospital), Philippe Rougier, MD, PhD (University of Versailles), Wolff Schmiegel, MD, PhD (Ruhr-Universität Bochum), Josep Tabernero, MD, PhD (Vall d'Hebron University Hospital), Eric Van Cutsem, MD, PhD (University Hospital Gasthuisberg), Cornelius J.H. van de Velde, MD, PhD (Leiden University Medical Center) and John R. Zalcberg, MD, PhD (Peter MacCallum Cancer Center)
Target Audience: Practicing clinicians, gastroenterologists, hepatologists, surgeons, medical oncologists, radiation oncologists, and clinical researchers who wish to review and update their knowledge and management of cancers of the gastrointestinal tract.

Click Here to Register for the Gastroenterology/Oncology CME

Event: World Congress on Gastrointestinal Cancer: Asian Perspectives
When/Where: August 2012 in Seoul, Korea
Gastroenterology/Oncology CME Event Summary: More information about this event and website will be coming soon.

Event: Fifth Asian Pacific Conference: Perspectives in Lung Cancer
When/Where: September 2012 in Hong Kong
Oncology CME Event Summary: More information about this event and website will be coming soon.

For more information about these 2012 Imedex Europe and Asia Continuing Medical Education Oncology events or to register:

                                 Email us at registration(at)imedex(dot)com
                                 Call us toll-free at 1(855) 276-6855
                                 Fax us 1 (512) 583-8379
                                 Or
                                 Online at http://www.imedex.com
About Imedex, LLC
Imedex® is an industry leader in providing accredited, independent continuing medical education to health care professionals. We develop high quality, scientific programming that translates the latest research into clinically relevant information. The activities have exceptional organization and outstanding educational value, with a proven sustained impact on disease management.

Our programs focus on improving patient care around the world. With over 50,000 e-learning experiences annually and more than 97,000 live meeting attendees since 2001, Imedex® truly educates the global healthcare community. At Imedex®, we believe that education is the best medicine. ®

Release issued by Audience Generation, LLC
Audience Generation is a forward thinking agency at the forefront of the digital revolution and is a nationally and internationally recognized provider of integrated marketing, advertising, and technology services and solutions that offer a new way to find, generate, and engage live, online, social and mobile audiences where they exist on demand.

Audience Generation is known for its creative strategy, actionable solutions and measurable approach to transforming the ways brands interact with their target audience where they exist in person, online, via social networks or on their mobile devices.

Audience Generation has produced winning traditional, online, e-commerce, social and mobile campaigns including mobile application solutions for Fortune 500, small and medium businesses, not-for-profit organizations, national and international associations and societies, and venture backed start-up companies across a variety of industry verticals around the World.

To learn how Audience Generation can find your ideal customer, reach them where they exist, build your brand and grow your bottom line please call us at 512-708-4678 or email us at growyourbusiness(at)audiencegeneration(dot)com or visit us at: http://www.audiencegeneration.com.

###

Share article on social media or email:

View article via:

Pdf Print

Contact Author

Marilyn Holman
Audience Generation
512-708-4678
Email >
Visit website